Coronary artery disease

Lore & Background

Coronary artery disease is characterized by atherosclerosis, a chronic inflammation of the arteries that causes them to harden and accumulate cholesterol plaques on the artery walls. The most common symptom is angina—chest pain or discomfort that may travel into the shoulder, arm, back, neck, or jaw—and in stable angina, symptoms occur with exercise or emotional stress, last less than a few minutes, and improve with rest. Shortness of breath may also occur, and sometimes no symptoms are present; in many cases, the first sign is a heart attack. Symptoms in females can differ from those in males, with the most common symptom reported by females being shortness of breath, along with extreme fatigue, sleep disturbances, indigestion, and anxiety.

Reader's Guide

Diagnosis may involve electrocardiogram, cardiac stress testing, coronary computed tomographic angiography, and coronary angiogram. Treatment includes the same measures as prevention—healthy diet, regular exercise, maintaining a healthy weight, and not smoking—along with medications such as antiplatelets, beta blockers, or nitroglycerin, and procedures like percutaneous coronary intervention or coronary artery bypass surgery in severe disease. However, in those with stable CAD, it is unclear if these procedures improve life expectancy or decrease heart attack risk. Primary prevention with statin medications reduces the incidence of sequelae, but there is limited evidence for the efficacy of early detection through screening of low-risk asymptomatic individuals.

Did You Know?

• Smoking just one cigarette per day about doubles the risk of coronary artery disease.
• Air pollution, both indoor and outdoor, is responsible for an estimated 15–20% of deaths from CAD.
• About half of cases are linked to genetics, with heritability estimated between 40% and 60%.

Anatomy of the Arterial Problem

Peripheral artery disease is a vascular condition characterized by the progressive narrowing or blockage of arteries that serve the body's extremities and organs, excluding the coronary and cerebral vessels. While the term "vascular" encompasses both arteries and veins, PAD specifically involves the arterial side—the network responsible for delivering oxygen-rich blood away from the heart. This distinguishes it clearly from peripheral veinous disease, which concerns the venous return pathway back to the heart. The condition can theoretically involve any arterial bed, yet it shows a strong predilection for the lower limbs. When the same atherosclerotic process strikes the heart's own vessels, clinicians label it coronary artery disease; when it affects cerebral arteries, the term cerebrovascular disease applies. PAD, then, occupies its own category as a form of peripheral vascular disease, most frequently manifesting in the legs but occasionally involving the arms, neck, or renal arteries. Understanding these distinctions matters because the clinical presentation, diagnostic workup, and therapeutic strategies differ depending on which vascular territory is compromised, even though the underlying plaque-driven pathology often shares common risk factors across all three sites.

What the Body Tells You

The hallmark of peripheral artery disease is intermittent claudication—a cramping pain in the calf muscles that appears during walking and eases once the patient rests. The mechanism is straightforward: exercising muscles demand more oxygen, and in a healthy individual the arteries dilate to meet that surge. In PAD, the narrowed vessel cannot increase flow adequately, so the muscle is starved of oxygen and signals pain until demand drops. Yet this classic picture is far from universal. Roughly two-thirds of affected individuals either remain entirely asymptomatic or present with atypical complaints. Other recognized manifestations include aching in the buttock, hip, or thigh; visible muscle wasting; loss of hair; skin that appears smooth, shiny, or feels cool; a diminished pedal pulse; coldness or numbness in the toes; and ulcers that refuse to heal. In the most advanced cases, obstruction becomes so severe that even resting tissue cannot be oxygenated—a state called critical limb ischemia—which can progress to gangrene or necessitate amputation. Diabetic patients face a thirtyfold higher risk of foot gangrene compared to those without diabetes, and many of these end-stage complications are irreversible.

Who Is at Risk and Why

Peripheral artery disease is overwhelmingly driven by atherosclerosis—the gradual accumulation of fatty plaque within arterial walls—particularly in individuals past the age of forty. However, other mechanisms such as arterial spasm, thrombosis, physical trauma, fibromuscular dysplasia, and vasculitis can also produce the narrowing seen in PAD. The single most powerful modifiable risk factor is cigarette smoking. Tobacco use in any form carries up to a tenfold elevated risk of developing PAD, and the relationship follows a dose-response curve: the more one smokes, the greater the danger. Even passive exposure to second-hand smoke has been shown to provoke harmful changes in the endothelial lining of blood vessels. Beyond smoking, the major contributors mirror those of atherosclerosis in general: hyperlipidemia, hypertension, diabetes mellitus, and chronic kidney disease. When a patient presents with three or more of these factors simultaneously, the combined risk of developing PAD climbs roughly tenfold. Demographic patterns also matter. PAD is approximately twice as prevalent in men as in women, and it affects people of color at roughly double the rate seen in white populations. Age remains a steady driver, with prevalence climbing sharply in older cohorts.

Finding It, Treating It, and the Global Toll

Diagnosis of PAD typically hinges on the ankle-brachial index, a ratio of systolic blood pressure at the ankle to that at the arm; a value below 0.90 confirms the condition. Duplex ultrasonography offers a non-invasive imaging alternative, while angiography provides the highest accuracy and the ability to perform interventional treatment in the same session—though it carries greater procedural risk. Whether routine screening in asymptomatic individuals is worthwhile remains unresolved, as adequate studies have not yet been conducted. For patients with claudication, the cornerstone of management is smoking cessation combined with a supervised exercise program. Pharmacologic options include statins, ACE inhibitors, and cilostazol. Aspirin, while not shown to benefit mild disease, is generally advised for more significant PAD because of the elevated heart-attack risk. Anticoagulants such as warfarin have not demonstrated a clear benefit. When conservative measures fail, surgical approaches—bypass grafting, angioplasty, and atherectomy—can restore flow. Globally, the burden is substantial. In 2015 an estimated 155 million people lived with PAD, and the condition claimed roughly 52,500 lives that year, a marked rise from the 16,000 deaths recorded in 1990. Prevalence climbs steeply with age, reaching nearly 19 percent among those in their late eighties in developed nations.